Therefore, although further investigations are required to determine the underlying mechanisms, our study shows the potential for combined aspirin and Compound C treatment as a pharmacological tool for the prevention and treatment of HER-2-positive breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.